ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

17,092Medicare Part D Prescriptions Filled, Including Refills

Rank: 130 out of 2343

$1.12M Total Retail Price of All Prescriptions

Rank: 83 out of 2343

533 Patients Receiving at Least One Drug in Part D
78%Patients 65 Years and Older
63% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Pennsylvania
Lower avg

Schedule Two
Controlled Substances

4% of this provider’s 533 patients filled at least one prescription for a schedule two drug, compared to an average of 7%.

Schedule Three
Controlled Substances

4% of this provider’s 533 patients filled at least one prescription for a schedule three drug, compared to an average of 7%.

Risky Drugs to Seniors

2% of this provider’s 13,241 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

24% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$66 was the average price of a prescription from this provider, compared to $58 among peers.

Prescriptions per Patient

32 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Pennsylvania
FUROSEMIDE 644 560 1 6
WARFARIN SODIUM 546 528 2 8
LEVOTHYROXINE SODIUM 462 338 3 2
SIMVASTATIN 461 380 4 1
AMLODIPINE BESYLATE 454 383 5 5
LISINOPRIL 452 380 6 3
METOPROLOL TARTRATE 361 333 7 7
TRAMADOL HCL 337 251 8 25
OMEPRAZOLE 311 220 9 4
NAMENDA 285 275 10 36
POTASSIUM CHLORIDE 276 249 11 18
METOPROLOL SUCCINATE 269 210 12 14
METFORMIN HCL 261 204 13 9
DONEPEZIL HCL 252 237 14 21
CITALOPRAM HBR 232 182 15 17
RISPERIDONE 221 196 16 61
ALENDRONATE SODIUM 212 118 17 28
ATORVASTATIN CALCIUM 207 145 18 10
IBUPROFEN 193 115 19 75
MIRTAZAPINE 193 158 19 41
TAMSULOSIN HCL 191 157 21 29
TRAZODONE HCL 189 111 22 53
OLANZAPINE 149 135 23 121
CARVEDILOL 147 110 24 27
QUETIAPINE FUMARATE 143 109 25 77
ALLOPURINOL 142 108 26 31
GLIMEPIRIDE 142 114 26 45
ESCITALOPRAM OXALATE 139 94 28 55
PREDNISONE 134 94 29 37
LAMOTRIGINE 127 81 30 194
CLONIDINE HCL 123 86 31 70
METOLAZONE 121 97 32 173
PANTOPRAZOLE SODIUM 120 104 33 22
BYSTOLIC 115 102 34 123
CIPROFLOXACIN HCL 112 88 35 72
CRESTOR 112 92 35 30
VENLAFAXINE HCL ER 111 73 37 87
HYDROCHLOROTHIAZIDE 110 106 38 11
SERTRALINE HCL 107 90 39 20
PHENYTOIN SODIUM EXTENDED 107 65 39 152
KLOR-CON M20 106 99 41 44
ATENOLOL 103 69 42 12
PROMETHAZINE HCL 98 70 R 43 222
DIVALPROEX SODIUM 96 32 44 105
CLOPIDOGREL 95 69 45 26
DILTIAZEM 24HR ER 95 85 45 76
GABAPENTIN 95 71 45 16
LOSARTAN POTASSIUM 93 67 48 19
NIFEDIPINE ER 93 90 48 89
AMOX TR-POTASSIUM CLAVULANATE 93 69 48 160
ADVAIR DISKUS 91 64 51 34
PAROXETINE HCL 86 84 52 66
NEXIUM 86 44 52 33
AMITRIPTYLINE HCL 81 45 R 54 117
CLOTRIMAZOLE-BETAMETHASONE 81 46 54 127
DIOVAN 80 79 56 23
PLAVIX 80 70 56 38
CYMBALTA 79 61 58 74
LEVETIRACETAM 78 49 59 104
LANTUS 77 66 60 51
DIGOXIN 77 77 60 35
FLUOXETINE HCL 77 45 60 82
HYDRALAZINE HCL 74 41 63 92
LOSARTAN-HYDROCHLOROTHIAZIDE 73 71 64 64
NOVOLIN 70-30 71 60 65 268
KLOR-CON M10 68 62 66 107
SPIRONOLACTONE 66 64 67 65
AMLODIPINE BESYLATE-BENAZEPRIL 66 55 67 59
BACLOFEN 65 14 69 161
SULFAMETHOXAZOLE-TRIMETHOPRIM 64 35 70 120
MUPIROCIN 63 29 71 260
POLYETHYLENE GLYCOL 3350 62 20 72 54
IPRATROPIUM-ALBUTEROL 61 57 73 99
AMOXICILLIN 60 38 74 118
NOVOLOG 60 56 74 110
SPIRIVA 60 37 74 48
BISOPROLOL-HYDROCHLOROTHIAZIDE 59 59 77 151
CYCLOBENZAPRINE HCL 57 21 R 78 109
LOVASTATIN 56 42 79 47
LACTULOSE 55 21 80 139
SEROQUEL 54 37 81 171
VERAPAMIL ER 53 33 82 95
RANITIDINE HCL 53 35 82 43
OXYBUTYNIN CHLORIDE ER 52 52 84 149
RAMIPRIL 51 35 85 90
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on May 12, 2008.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.